Skip Navigation



Hum. Reprod. Advance Access published online on September 30, 2004
Human Reproduction, doi:10.1093/humrep/deh496
© 2004 by European Society of Human Reproduction and Embryology
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
19/12/2767    most recent
deh496v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gersak, K.
Right arrow Articles by Shelling, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gersak, K.
Right arrow Articles by Shelling, A. N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received May 4, 2004
Accepted August 2, 2004

Article

A novel 30 bp deletion in the FOXL2 gene in a phenotypically normal woman with primary amenorrhoea: Case report

Ksenija Gersak 1*, Sarah E. Harris 2, Wendy J. Smale 3, and Andrew N. Shelling 3

1 Division of Medical Genetics, Department of Obstetrics and Gynaecology, University Medical Centre Ljubljana, Ljubljana, Slovenia
2 Department of Psychology, University of Edinburgh, 7 George Square, Edinburgh EH8 9JZ, UK
3 Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

* To whom correspondence should be addressed. E-mail: ksenija.gersak{at}mf.uni-lj.si.


  Abstract

In a Slovene patient with primary amenorrhoea without an association with blepharophimosis/ptosis/epicanthus inversus syndrome (BPES), a novel 30 bp deletion was identified in the FOXL2 gene. We report the clinical features of this woman who has spontaneously conceived and delivered two live healthy babies. The novel deletion was predicted to remove 10 out of 14 alanines (A221_A230del), from the polyalanine tract downstream of the winged helix/forkhead domain of the FOXL2 protein. The patient's parents and sister were shown not to carry this deletion. Despite seeing an anovulatory secretory pattern of FSH, follicles developed spontaneously. Persistent and consistent monitoring have practical implications for genetic and fertility counselling in the era when women with premature ovarian failure usually seek ovum donation. The role of FOXL2 in the development of infertility is still unclear, but several lines of evidence suggest that it plays a central role in follicle development.

Keywords: fluctuating FSH; FOXL2; primary amenorrhoea.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mol Hum ReprodHome page
K. Duffin, R.A.L. Bayne, A.J. Childs, C. Collins, and R.A. Anderson
The forkhead transcription factor FOXL2 is expressed in somatic cells of the human ovary prior to follicle formation
Mol. Hum. Reprod., December 1, 2009; 15(12): 771 - 777.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
B. Wang, L. Li, F. Ni, J. Song, J. Wang, Y. Mu, X. Ma, and Y. Cao
Mutational analysis of SAL-Like 4 (SALL4) in Han Chinese women with premature ovarian failure
Mol. Hum. Reprod., September 1, 2009; 15(9): 557 - 562.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
P Laissue, B Lakhal, B A Benayoun, A Dipietromaria, R Braham, H Elghezal, P Philibert, A Saad, C Sultan, M Fellous, et al.
Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2
J. Med. Genet., July 1, 2009; 46(7): 455 - 457.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
B. A. Benayoun, F. Batista, J. Auer, A. Dipietromaria, D. L'Hote, E. De Baere, and R. A. Veitia
Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations
Hum. Mol. Genet., February 15, 2009; 18(4): 632 - 644.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
B. Mandon-Pepin, P. Touraine, F. Kuttenn, C. Derbois, A. Rouxel, F. Matsuda, A. Nicolas, C. Cotinot, and M. Fellous
Genetic investigation of four meiotic genes in women with premature ovarian failure
Eur. J. Endocrinol., January 1, 2008; 158(1): 107 - 115.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Batista, D. Vaiman, J. Dausset, M. Fellous, and R. A. Veitia
Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics
PNAS, February 27, 2007; 104(9): 3330 - 3335.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
K.R. Barnett, C. Schilling, C.R. Greenfeld, D. Tomic, and J.A. Flaws
Ovarian follicle development and transgenic mouse models
Hum. Reprod. Update, September 1, 2006; 12(5): 537 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
W. J. Watkins, S. E. Harris, M. J. Craven, A. L. Vincent, I. M. Winship, K. Gersak, and A. N. Shelling
An investigation into FOXE1 polyalanine tract length in premature ovarian failure
Mol. Hum. Reprod., March 1, 2006; 12(3): 145 - 149.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
L. Moumne, M. Fellous, and R. A. Veitia
Deletions in the polyAlanine-containing transcription factor FOXL2 lead to intranuclear aggregation
Hum. Mol. Genet., December 1, 2005; 14(23): 3557 - 3564.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.